Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STR-324 in Post-operative Pain
NCT04582786Phase 2Unknown
- Sponsor
- Alaxia
- Start
- Dec 2020
- Primary completion
- Jan 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of STR-324 in postoperative pain, sponsored by Alaxia. Status: unknown.
02
Drugs
STR-324
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04582786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04582786.